Biomedical Application of Nanoparticles (Record no. 3764)

MARC details
000 -LEADER
fixed length control field 01378 a2200325 4500
001 - CONTROL NUMBER
control field 1498750028
005 - DATE AND TIME OF LATEST TRANSACTION
control field 20250317111557.0
008 - FIXED-LENGTH DATA ELEMENTS--GENERAL INFORMATION
fixed length control field 250312042017xx 84 eng
020 ## - INTERNATIONAL STANDARD BOOK NUMBER
International Standard Book Number 9781498750028
037 ## - SOURCE OF ACQUISITION
Source of stock number/acquisition Taylor & Francis
Terms of availability GBP 47.99
Form of issue BB
040 ## - CATALOGING SOURCE
Original cataloging agency 01
041 ## - LANGUAGE CODE
Language code of text/sound track or separate title eng
072 7# - SUBJECT CATEGORY CODE
Subject category code PSD
Source thema
072 7# - SUBJECT CATEGORY CODE
Subject category code TBN
Source thema
072 7# - SUBJECT CATEGORY CODE
Subject category code TDCW
Source thema
072 7# - SUBJECT CATEGORY CODE
Subject category code PSD
Source bic
072 7# - SUBJECT CATEGORY CODE
Subject category code TBN
Source bic
072 7# - SUBJECT CATEGORY CODE
Subject category code TDCW
Source bic
072 7# - SUBJECT CATEGORY CODE
Subject category code MED072000
Source bisac
072 7# - SUBJECT CATEGORY CODE
Subject category code SCI010000
Source bisac
072 7# - SUBJECT CATEGORY CODE
Subject category code SCI049000
Source bisac
072 7# - SUBJECT CATEGORY CODE
Subject category code SCI086000
Source bisac
072 7# - SUBJECT CATEGORY CODE
Subject category code 610.28
Source bisac
100 1# - MAIN ENTRY--PERSONAL NAME
Personal name Bertrand Henri Rihn
245 10 - TITLE STATEMENT
Title Biomedical Application of Nanoparticles
250 ## - EDITION STATEMENT
Edition statement 1
260 ## - PUBLICATION, DISTRIBUTION, ETC.
Name of publisher, distributor, etc. CRC Press
Date of publication, distribution, etc. 20170905
300 ## - PHYSICAL DESCRIPTION
Extent 348 p
520 ## - SUMMARY, ETC.
Expansion of summary note Biomedical Application of Nanoparticles explores nanoparticles, their chemical and physicals properties, and how they interact in biological systems with proteins, immune system and targeted cells. Risk assessment of nanoparticles for human is described, including: cellular paradigms, transcriptomics and toxicogenomics. Finally, the applications of nanoparticles in medicine and antioxidant regenerative therapeutics are presented in several chapters with emphasis on how nanoparticles enhance transport of drugs across biological membrane barriers and therefore may enhance drug bioavailability.

No items available.